Ascendis Pharma A (ASND) Intangibles (2012 - 2026)

Ascendis Pharma A has disclosed Intangibles across 15 years of filings, most recently posting $4.3 million for Q1 2026.

• Intangibles for Q1 2026 came in at $4.3 million, up 5.04% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.3 million (up 5.04% YoY), and the FY2025 annual result was $4.3 million, changed 0.33% from the prior year.
• Intangibles came in at $4.3 million for Q1 2026 at Ascendis Pharma A, roughly flat from $4.3 million in the prior quarter.
• In the past five years, Intangibles ranged from a high of $5.8 million in Q1 2022 to a low of $2.3 million in Q4 2022.
• The 5-year median for Intangibles is $4.5 million (2024), against an average of $4.4 million.
• Across the five-year window, Intangibles tumbled 65.34% in 2022 and surged 74.24% in 2024, its largest moves.
• Ascendis Pharma A's Intangibles stood at $2.3 million in 2022, then grew by 8.97% to $2.5 million in 2023, then soared by 74.24% to $4.3 million in 2024, then advanced by 0.33% to $4.3 million in 2025, then increased by 0.01% to $4.3 million in 2026.
• The last three Intangibles figures came in at $4.3 million (Q1 2026), $4.3 million (Q4 2025), and $4.4 million (Q3 2025), per Business Quant data.